Celebration of Partnership Between Gift of Life Biologics and Cellex Cell Professionals in Cell and Gene Therapy

Partnership Highlights Between Gift of Life Biologics and Cellex Cell Professionals

Gift of Life Biologics and Cellex Cell Professionals GmbH are proud to announce the ongoing success of their partnership that began in 2022. This collaboration focuses on delivering high-quality cellular starting materials that are crucial for producing advanced drug products in cell and gene therapy (CGT).

Excellence in Quality and Customization

The partnership is built upon strong foundational principles of quality and mutual trust. Gift of Life Biologics, a leading supplier of cellular starting materials in the United States, has consistently provided customized materials that meet the specific needs of donors. Each batch delivered to Cellex Cell Professionals is tailored to comply with the complex requirements of the CGT processes.

Carla Kreissig, Managing Director of Cellex Cell Professionals, expresses her enthusiasm for the partnership, highlighting that, while the company has its own donor center and database, the collaboration with Gift of Life Biologics is essential. It ensures they can meet all customer requests related to donor specifications, ultimately delivering transformative therapies to patients who need them most.

Setting New Standards in CGT

The delivery of these customized cellular materials from Gift of Life's advanced, FDA-registered facility has established a new benchmark for quality and innovation in the CGT industry. The expertise of Cellex in drug manufacturing complements this, allowing them to develop high-standard CGT products that adhere to regulatory requirements.

"We are thrilled with the advancements we've made with Gift of Life Biologics over the past several years," Kreissig added. "Their commitment to providing us with the highest quality starting materials has significantly contributed to our success."

Eric Strati, CEO of Gift of Life Biologics, emphasized the integrated platform they've created, which combines donor acquisition through to finished products, positioning life-science organizations to efficiently develop and market transformative therapies across the U.S. and Europe.

Both companies are eager to expand their partnership further, pledging to enhance services, expertise, and quality in the field of cell-based therapies.

Future Growth in Cell and Gene Therapy

As the collaboration continues to grow, both companies are dedicated to pushing the boundaries in CGT, striving to provide the highest level of service and support to facilitate the production of life-changing therapies for patients around the world.

For more details about Gift of Life Biologics and Cellex Cell Professionals, visit their respective websites at www.giftoflifebio.com and www.cellex.me/en. The partnership aims not only to improve current processes but to drive innovations that could revolutionize treatment options available to patients in need.

This collaboration exemplifies how strategic partnerships in the biopharmaceutical industry can lead to meaningful advancements in healthcare.